Antidepressant Medication Side Effects Including Weight, Blood Pressure Variations Differ Depending on Medication

• A large latest study determined that the adverse reactions of antidepressants range considerably by drug.
• Some drugs resulted in decreased mass, whereas other medications caused added mass.
• Cardiac rhythm and BP furthermore diverged significantly across drugs.
• Patients encountering continuing, severe, or concerning unwanted effects should discuss with a physician.

New studies has revealed that antidepressant side effects may be more extensive than earlier believed.

The large-scale study, published on October 21, examined the influence of antidepressant medications on in excess of 58,000 participants within the initial eight weeks of beginning medication.

These investigators examined 151 investigations of 30 medications typically prescribed to manage clinical depression. Although not every patient experiences side effects, several of the most common observed in the study were changes in weight, arterial pressure, and metabolic indicators.

The study revealed striking variations between antidepressant drugs. For instance, an 60-day treatment period of agomelatine was associated with an mean reduction in body weight of about 2.4 kilograms (about 5.3 lbs), while maprotiline patients added nearly 2 kg in the equivalent period.

There were also, significant changes in cardiac function: fluvoxamine often would reduce cardiac rhythm, while nortriptyline raised it, producing a disparity of approximately 21 BPM between the both treatments. BP fluctuated as well, with an 11 mmHg disparity observed between one drug and doxepin.

Healthcare professionals noted that the research's results are not novel or surprising to psychiatric specialists.

"Clinicians have long recognized that various antidepressants range in their impacts on weight, blood pressure, and other metabolic indicators," a specialist stated.

"However, what is notable about this research is the comprehensive, relative quantification of these variations among a extensive spectrum of physical indicators utilizing information from more than 58,000 participants," the specialist added.

The investigation offers robust proof of the degree of unwanted effects, certain of which are more common than different reactions. Typical antidepressant adverse reactions may encompass:

• stomach problems (queasiness, loose stools, constipation)
• sexual problems (lowered desire, anorgasmia)
• weight changes (gain or reduction, depending on the drug)
• rest issues (inability to sleep or sleepiness)
• oral dehydration, sweating, head pain

At the same time, rarer but medically important unwanted effects may encompass:

• increases in blood pressure or heart rate (notably with SNRIs and certain tricyclics)
• hyponatremia (especially in senior patients, with SSRIs and serotonin-norepinephrine reuptake inhibitors)
• elevated hepatic parameters
• QTc extension (risk of arrhythmia, particularly with citalopram and some tricyclic antidepressants)
• emotional blunting or lack of interest

"A key factor to note here is that there are various different categories of antidepressants, which result in the varying unwanted pharmaceutical side effects," a different specialist stated.

"Moreover, depression treatments can affect each patient variably, and negative side effects can range based on the specific pharmaceutical, dose, and personal factors including metabolism or comorbidities."

Although some adverse reactions, such as fluctuations in rest, hunger, or stamina, are reasonably frequent and frequently enhance with time, other effects may be less frequent or longer-lasting.

Antidepressant adverse reactions may differ in intensity, which could warrant a adjustment in your drug.

"An change in depression drug may be necessary if the person experiences continuing or unacceptable adverse reactions that do not improve with time or supportive measures," one expert stated.

"Moreover, if there is an appearance of recent medical conditions that may be exacerbated by the present medication, for instance elevated BP, arrhythmia, or substantial mass addition."

Individuals may furthermore contemplate speaking with your doctor about any deficiency of significant improvement in depressive or anxiety signs after an adequate evaluation duration. The sufficient trial period is typically 4–8 weeks at a treatment dosage.

Patient preference is additionally crucial. Certain patients may prefer to avoid particular unwanted effects, including intimacy issues or {weight gain|increased body weight|mass addition